Skip to main content

Horizon Therapeutics plc Announces Significant Expansion of East Coast Research and Development and Technical Operations Capability | Horizon Therapeutics plc

By January 7, 2022News
Cursor and Horizon Therapeutics plc Announces Significant Expansion of East Coast Research and Development and Technical Operations Capability Horizon Therapeutics plc

Cursor and Horizon Therapeutics plc Announces Significant Expansion of East Coast Research and Development and Technical Operations Capability Horizon Therapeutics plc

DUBLIN–(BUSINESS WIRE)–Jan. 6, 2022– Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has signed a long-term, full-building lease with Alexandria Real Estate Equities, Inc. to be the first tenant at the Alexandria Center® at Traville Gateway campus in Rockville, Maryland. When completed, the state-of-the-art facility will serve as the company’s primary East Coast research and development and technical operations hub. Construction at the 192,000-square-foot site is underway and Horizon expects to start work on interior improvements in 2023. Additional terms of the agreement were not disclosed.

 

{iframe}https://ir.horizontherapeutics.com/news-releases/news-release-details/horizon-therapeutics-plc-announces-significant-expansion-east{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.